Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Transgender people

Studies confirm that hormone levels in trans women are not greatly affected by PrEP, or vice versa

News
22 July 2021
The search for a cure

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir

News
21 July 2021
New & experimental HIV treatments

HIV: Could Another Two-Drug Regimen Be on the Horizon?

Editor's pick
Medscape (requires free registration)
21 July 2021
PrEP science

PrEP failures in African programmes are rare, but some are happening in people with good adherence

News
21 July 2021
Viral load

Viral suppression in Uganda improved by more viral load tests, done faster

News
20 July 2021
Improving HIV care

Long-acting injectable HIV treatment is feasible, even during COVID-19

News
20 July 2021
Injectable & long-acting HIV treatment

Twice-a-year injected drug shows promise for first-line HIV treatment

News
19 July 2021
HIV treatment for children & young people

Adolescent-centred interventions lead to a 30-percentage-point increase in viral suppression in Namibia, and a 20-percentage-point increase in Nigeria

News
19 July 2021
Retention & linkage to care

Healthcare workers in Cape Town ambivalent about patients who disengage from HIV treatment

News
18 July 2021
Treatment guidelines

Most countries with the greatest burden of HIV still don’t recommend dolutegravir for all

News
18 July 2021
Treatment guidelines

WHO publishes new Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring

Editor's pick
World Health Organization
17 July 2021
New & experimental HIV treatments

Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing therapy

News
17 July 2021
HIV treatment

Efavirenz/emtricitabine/tenofovir disoproxil fumarate Factsheet

About HIV
July 2021
Treatment outcomes & life expectancy

Americans Living With HIV Have Near-Normal Life Expectancy: Study

Editor's pick
HealthDay News
8 July 2021
HIV treatment

Efavirenz/emtricitabine/tenofovir disoproxil fumarate Detailed information

About HIV
July 2021
Ageing & HIV

Yvonne Richards on ageing with HIV – GROWS project Video

July 2021
HIV treatment

Efavirenz Detailed information

About HIV
July 2021
Neurological & cognitive problems

New predictors for peripheral neuropathy found in study of people living with HIV

News
6 July 2021
HIV treatment

Emtricitabine Factsheet

About HIV
July 2021
Bad science & bogus treatments

Hospitals across East Africa offer controversial anti-gay counselling

Editor's pick
OpenDemocracy
5 July 2021
Pharmaceutical industry

Gilead files long-acting HIV med for patients running out of options

Editor's pick
FierceBiotech
1 July 2021
Starting treatment

Starting HIV Treatment Is Personal, Not One-Size-Fits-All

Editor's pick
TheBody
1 July 2021
HIV treatment

Lamivudine Factsheet

About HIV
June 2021
Pharmaceutical industry

GSK puts long-acting injectables at heart of HIV growth plans, downplays threat of oral rival from Gilead and Merck

Editor's pick
FiercePharma
29 June 2021